Provides a clear and concise summary of the scientific data on treatment efficacy which can contribute to a better understanding among the general public on the status of the field of psychiatric treatment research for the severely mentally ill. Includes efficacy of treatments for: schizophrenia, bipolar disorder, major depression, panic disorder, obsessive-compulsive disorder, geropsychiatric patients with severe mental illness, psychiatric disorders in children and adolescents, and psychiatric rehabilitation. Charts and tables.
The traditional boundary lines within the professional practice of psychology are changing, and major practice issues, such as prescription and hospital admitting privileges for psychologists, need to be expediently and adequately addressed. As many psychologists have come to realize, appropriate pharmacotherapy can be a useful adjunct to psychotherapy. Even professionals who do not use psychotropics in their own practice require at least a minimum degree of knowledge about the effects of these drugs on their patients. For example, a school counselor with an understanding of anticonvulsant drugs or methylphenidate, may be better able to plan an optimal program for learning disabled child who uses these drugs. The Pharmacologic Basis of Psychotherapeutics starts with a brief history (written by guest author Patrick DeLeon) of the movement to obtain prescription privileges for psychologists, including the arguments on both sides of the issue. It then describes the various purported mechanisms by which psychotropic drugs elicit their effects in the human body. The various drugs are introduced, and the processes of absorption, distribution and elimination, as well as the influence of age and disease on these processes are also discussed. Attention is given to the methods of administration, adverse reactions, and drug interactions. Based on the authors' experience in teaching pharmacopsychology, this text reflects their concern that psychologists be provided with a reference source that is both pharmacologically correct and specifically relevant to the expanded professional practice of psychology. Because it assumes no prior knowledge of pharmacotherapy, this book is appropriate for the graduate psychology student or post-graduate psychologist in clinical practice. An Editorial Advisory Committee, comprised of distinguished academics, researchers, and clinical psychologists was established to help ensure that the focus and leveling of the book was appropriately directed to the needs and abilities of both graduate psychology students and psychologists.
This Clinical Handbook for the Management of Mood Disorders will equip clinicians with the knowledge to refine their diagnostic skills and implement treatment plans for mood disorders based on the most up-to-date evidence on interventions that work. Covering the widest range of treatments and techniques, it provides clear guidance for the management of all types and subtypes of both minor and major depression. Chapters cover the latest and most innovative treatments, including use of ketamine, deep brain stimulation and transcranial magnetic stimulation, effective integration of pharmacological and psychotherapeutic approaches, as well as providing a thought-provoking look at the future research agenda and the potential for reliable biomarkers. This is the most comprehensive review of depression available today. Written and edited by leading experts mostly from Columbia University, this is an essential resource for anyone involved in the care and treatment of patients with mood disorders.
The body of knowledge that we have accumulated about the causes and nature of schizophrenia is prodigious, and the repertoire of evidence-based treatments is substantial and increasing. Comprehensive Care of Schizophrenia distills this corpus into the essential information that clinicians who care for persons with schizophrenia need to know. The second edition of the popular volume is thoroughly updated, offering new information on the advances in research and management since the first edition was published a decade ago. Chapters are streamlined to keep content as concise as possible, while key sections have been revised and expanded to include new information on drug therapy and advice on patient care. People with schizophrenia can suffer from multiple morbidities and disabilities, and thus may require a variety of treatments, both pharmacological and psychosocial. To cover the complex and growing field of schizophrenia management, renowned psychiatrists Jeffrey Lieberman and Robin Murray have recruited a distinguished group of researchers, practitioners and consumers of mental health care. This guide delves into to all aspects of the clinical management of schizophrenia for both the health care professional who treats patients as well as the researcher interested in the advances made in the field and their clinical application.
Extensively revised and updated this edition reflects the progress and developments in the field. With 127 chapters and over 400 contributors this book is a truly comprehensive exposition of the specialty of psychiatry. Written by well-known and highly regarded experts from around the world, it takes a patient-centered approach making it an indispensable resource for all those involved in the care of patients with psychiatric disorders. For this new edition, the section on the Neuroscientific Foundations of Psychiatry has been completely revised, with a new author team recruited by Section Editors Jonathan Polan and Eric Kandel. The final section, Special Populations and Clinical Settings, features important new chapters on today’s most urgent topics, including the homeless, restraint and geriatric psychiatry. Key features include: Coverage of the entire field of psychiatry, from psychoanalysis to pharmacology and brain imaging, including family relations, cultural influence and change, epidemiology, genetics and behavioral medicine Clinical vignettes describing current clinical practice in an attractive design Numerous figures and tables that facilitate learning and comprehension appear throughout the text Clear comparisons of the DSM-IV-TR and ICD-10 criteria for easy understanding in a global context Diagnostic and treatment decision trees to help both the novice and experienced reader The chapter on Cognitive Behavioral Therapies by Edward Friedman, Michael Thase and Jesse Wright is freely available. Please click on Read Excerpt 2 above to read this superb exposition of these important therapies.
